Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05129293 · ClinicalTrials.gov registry record · NA

Improving Prospective Memory Via Telehealth

A NA study of Multiple Sclerosis, sponsored by Trinity Health Of New England.

Completed
Registry status
NA
Development phase
35
Enrollment target
1
Study location

NCT05129293 is a NA study of Multiple Sclerosis that has completed, run by Trinity Health Of New England. The registered enrollment target is 35 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05129293, a NA study of Multiple Sclerosis, has completed, sponsored by Trinity Health Of New England.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target
1
Study location

Study Summary

Up to 70% of persons with multiple sclerosis (PwMS) experience cognitive impairment, which can have a significant impact on several aspects of their daily lives. One cognitive domain that has been shown to impact daily functioning, but is understudied in MS, is prospective memory (PM). While there have been successful PM interventions in other clinical populations, to date there has not been a specific PM intervention for PwMS that has been tested in a clinical trial. The study will be a double-masked randomized feasibility trial, with 18 participants randomized to a PM intervention and 18 participants randomized to an active control (psychoeducation). Participants will meet with an interventionist twice a week for four weeks. Feasibility will be assessed via 1) recruitment, enrollment, and retention; 2) adherence to the treatment; 3) treatment credibility and expectancy; and 4) treatment satisfaction. A preliminary effect size (Cohen's d) will be computed for the group difference using participants' performance on the Memory for Intentions Test, which will be given at baseline (week 1) and post-treatment (week 6). Participants will also complete a battery of neuropsychological measures as part of their baseline and post-treatment assessments.

Conditions Studied

Interventions

  • BEHAVIORAL Educational
  • BEHAVIORAL Prospective Memory Intervention

Study Locations (1)

Connecticut

  • Mount Sinai Rehabilitation Hospital - Hartford

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2021-11-01
Est. Completion 2023-06-30
Phase NA

Sponsor

Trinity Health Of New England

20 total trials

What the Registry Record Tells You About NCT05129293

The ClinicalTrials.gov registry entry for NCT05129293 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (94% lower). The listed sponsor is Trinity Health Of New England, which has 20 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which Educational is the first listed.

NCT05129293 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT05129293 about?

NCT05129293 is a clinical study titled "Improving Prospective Memory Via Telehealth". Up to 70% of persons with multiple sclerosis (PwMS) experience cognitive impairment, which can have a significant impact on several aspects of their daily lives. One cognitive domain that has been shown to impact daily functioning, but is understudied in MS, is prospective memory (PM). While there h...

What is the current status of trial NCT05129293?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2021-11-01. Estimated completion is 2023-06-30.

What conditions does trial NCT05129293 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT05129293?

The interventions under investigation include: Educational (BEHAVIORAL), Prospective Memory Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05129293?

This trial is sponsored by Trinity Health Of New England, which has 20 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05129293 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.